GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (SZSE:300357) » Definitions » Cyclically Adjusted PS Ratio

Zhejiang Wolwo Bio-Pharmaceutical Co (SZSE:300357) Cyclically Adjusted PS Ratio : 16.45 (As of Jun. 05, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Wolwo Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Zhejiang Wolwo Bio-Pharmaceutical Co's current share price is ¥20.89. Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥1.27. Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 16.45.

The historical rank and industry rank for Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300357' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 14.29   Med: 32.03   Max: 68.93
Current: 15.95

During the past years, Zhejiang Wolwo Bio-Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 68.93. The lowest was 14.29. And the median was 32.03.

SZSE:300357's Cyclically Adjusted PS Ratio is ranked worse than
96.61% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs SZSE:300357: 15.95

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zhejiang Wolwo Bio-Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.436. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥1.27 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Wolwo Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Wolwo Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Zhejiang Wolwo Bio-Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 64.81 54.98 26.09 16.49

Zhejiang Wolwo Bio-Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.95 17.34 20.00 16.49 16.82

Competitive Comparison of Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Zhejiang Wolwo Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=20.89/1.27
=16.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Zhejiang Wolwo Bio-Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.436/115.1156*115.1156
=0.436

Current CPI (Mar. 2025) = 115.1156.

Zhejiang Wolwo Bio-Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.113 99.500 0.131
201509 0.163 100.500 0.187
201512 0.128 100.600 0.146
201603 0.135 102.200 0.152
201606 0.120 101.400 0.136
201609 0.201 102.400 0.226
201612 0.141 102.600 0.158
201703 0.157 103.200 0.175
201706 0.158 103.100 0.176
201709 0.245 104.100 0.271
201712 0.176 104.500 0.194
201803 0.204 105.300 0.223
201806 0.213 104.900 0.234
201809 0.319 106.600 0.344
201812 0.220 106.500 0.238
201903 0.264 107.700 0.282
201906 0.260 107.700 0.278
201909 0.431 109.800 0.452
201912 0.266 111.200 0.275
202003 0.211 112.300 0.216
202006 0.285 110.400 0.297
202009 0.442 111.700 0.456
202012 0.277 111.500 0.286
202103 0.315 112.662 0.322
202106 0.349 111.769 0.359
202109 0.519 112.215 0.532
202112 0.359 113.108 0.365
202203 0.377 114.335 0.380
202206 0.365 114.558 0.367
202209 0.595 115.339 0.594
202212 0.374 115.116 0.374
202303 0.350 115.116 0.350
202306 0.388 114.558 0.390
202309 0.549 115.339 0.548
202312 0.333 114.781 0.334
202403 0.413 115.227 0.413
202406 0.407 114.781 0.408
202409 0.575 115.785 0.572
202412 0.373 114.893 0.374
202503 0.436 115.116 0.436

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Wolwo Bio-Pharmaceutical Co  (SZSE:300357) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zhejiang Wolwo Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Wolwo Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Wolwo Bio-Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Zhejiang Province, Huzhou, CHN, 313299
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a Chinese bio-pharmaceutical company. It is engaged in the research development, production and sales of allergic diseases diagnosis and treatment products. The product portfolio of the company covers dust mites drops, dust mites skin prick diagnosis kit, silk, and others.
Executives
Hu Geng Xi Directors, executives
Zhang Lu Directors, executives
Wang Li Hong Directors, executives
Director
Li Qin Supervisors
Wang Xin Hua Secretary, Director
Li Xiao Nan Supervisors

Zhejiang Wolwo Bio-Pharmaceutical Co Headlines

No Headlines